These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19347127)

  • 1. [Management of congenital nasolacrimal duct obstruction].
    Castelo Branco Neto E; Castelo Branco B; Cardoso CC; Carvalho RG; Mota E; Castelo Branco A
    Arq Bras Oftalmol; 2009; 72(1):75-8. PubMed ID: 19347127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crigler Massage for Congenital Blockade of Nasolacrimal Duct.
    Durrani J
    J Coll Physicians Surg Pak; 2017 Mar; 27(3):145-148. PubMed ID: 28406772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital nasolacrimal system obstruction.
    Kushner BJ
    Arch Ophthalmol; 1982 Apr; 100(4):597-600. PubMed ID: 6896140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital nasolacrimal duct obstruction in Japanese infants: its incidence and treatment with massage.
    Noda S; Hayasaka S; Setogawa T
    J Pediatr Ophthalmol Strabismus; 1991; 28(1):20-2. PubMed ID: 2019953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Congenital nasolacrimal obstruction: successful treatment factors].
    Schellini SA; Viveiros MM; Jaqueta E; Padovani CR; Padovani CR
    Arq Bras Oftalmol; 2005; 68(2):241-4. PubMed ID: 15905948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success rate and cause of failure for late probing for congenital nasolacrimal duct obstruction.
    Maheshwari R
    J Pediatr Ophthalmol Strabismus; 2008; 45(3):168-71. PubMed ID: 18524195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservative management of congenital nasolacrimal duct obstruction.
    Nucci P; Capoferri C; Alfarano R; Brancato R
    J Pediatr Ophthalmol Strabismus; 1989; 26(1):39-43. PubMed ID: 2915312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Success of probing for congenital nasolacrimal duct obstruction in children under 10 years of age.
    Thongthong K; Singha P; Liabsuetrakul T
    J Med Assoc Thai; 2009 Dec; 92(12):1646-50. PubMed ID: 20043568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The results of late probing in congenital nasolacrimal duct obstruction.
    Zilelioğlu G; Hoşal BM
    Orbit; 2007 Mar; 26(1):1-3. PubMed ID: 17510863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Lacrimal Sac Massage in Management of Congenital Nasolacrimal Duct Obstruction in Infants: An Observational Study of 853 Cases from a Single Institute of Eastern Asia.
    Nanda D; Sarkar M
    Middle East Afr J Ophthalmol; 2022; 29(4):216-219. PubMed ID: 38162564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of congenital nasolacrimal duct obstruction--latin american study.
    Schellini SA; Ariki CT; Sousa RL; Weil D; Padovani CR
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):389-92. PubMed ID: 23924988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of probing for congenital nasolacrimal duct obstruction in children older than 13 months of age.
    Maheshwari R
    Indian J Ophthalmol; 2005 Mar; 53(1):49-51. PubMed ID: 15829747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage.
    Karti O; Karahan E; Acan D; Kusbeci T
    Int Ophthalmol; 2016 Dec; 36(6):845-849. PubMed ID: 26948127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrostatic pressure as an office procedure for congenital nasolacrimal duct obstruction.
    Stolovitch C; Michaeli A
    J AAPOS; 2006 Jun; 10(3):269-72. PubMed ID: 16814182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasolacrimal Duct Probing under Topical Anesthesia for Congenital Nasolacrimal Duct Obstruction in Taiwan.
    Hung CH; Chen YC; Lin SL; Chen WL
    Pediatr Neonatol; 2015 Dec; 56(6):402-7. PubMed ID: 26026949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the success rates of endoscopic-assisted probing in the treatment of membranous congenital nasolacrimal duct obstruction between younger and older children and its correlation with the thickness of the membrane at the Valve of Hasner.
    Gupta N; Neeraj C; Smriti B; Sima D
    Orbit; 2018 Aug; 37(4):257-261. PubMed ID: 29040026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Predictive of Success in Probing for Congenital Nasolacrimal Duct Obstruction.
    Beato J; Mota Á; Gonçalves N; Santos-Silva R; Magalhães A; Breda J; Falcão-Reis F
    J Pediatr Ophthalmol Strabismus; 2017 Mar; 54(2):123-127. PubMed ID: 27977034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Success rates of primary probing for congenital nasolacrimal obstruction in children.
    Arora S; Koushan K; Harvey JT
    J AAPOS; 2012 Apr; 16(2):173-6. PubMed ID: 22525175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of balloon catheter dilatation and silicon intubation as the secondary treatment for congenital nasolacrimal duct obstruction after failed primary probing].
    Hu M; Wu Q; Fan YW; Cao WW; Lin Q; Yu G
    Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):123-8. PubMed ID: 26906708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.